Human low-density lipoprotein receptor plays an important role in hepatitis B virus infection.
Hepatitis B virus (HBV) chronically infects more than 240 million people worldwide, resulting in chronic hepatitis, cirrhosis, and hepatocellular carcinoma. HBV vaccine is effective to prevent new HBV infection but does not offer therapeutic benefit to hepatitis B patients. Neither are current antiv...
| Main Authors: | , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Public Library of Science (PLoS)
2021-07-01
|
| 叢編: | PLoS Pathogens |
| 在線閱讀: | https://doi.org/10.1371/journal.ppat.1009722 |